- Home
- HRMY vs TRMD Comparison
HRMY vs TRMD Comparison
Compare HRMY & TRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- TRMD
- Stock Information
- Founded
- HRMY 2017
- TRMD 1889
- Country
- HRMY United States
- TRMD United Kingdom
- Employees
- HRMY N/A
- TRMD N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- TRMD Marine Transportation
- Sector
- HRMY Health Care
- TRMD Consumer Discretionary
- Exchange
- HRMY Nasdaq
- TRMD Nasdaq
- Market Cap
- HRMY 1.8B
- TRMD 1.7B
- IPO Year
- HRMY 2020
- TRMD N/A
- Fundamental
- Price
- HRMY $34.00
- TRMD $18.23
- Analyst Decision
- HRMY Strong Buy
- TRMD Buy
- Analyst Count
- HRMY 9
- TRMD 1
- Target Price
- HRMY $54.44
- TRMD $23.00
- AVG Volume (30 Days)
- HRMY 642.5K
- TRMD 993.3K
- Earning Date
- HRMY 08-05-2025
- TRMD 08-14-2025
- Dividend Yield
- HRMY N/A
- TRMD 21.95%
- EPS Growth
- HRMY 13.13
- TRMD N/A
- EPS
- HRMY 2.62
- TRMD 4.74
- Revenue
- HRMY $744,852,000.00
- TRMD $1,444,200,000.00
- Revenue This Year
- HRMY $20.10
- TRMD N/A
- Revenue Next Year
- HRMY $18.01
- TRMD N/A
- P/E Ratio
- HRMY $13.10
- TRMD $3.85
- Revenue Growth
- HRMY 20.62
- TRMD N/A
- 52 Week Low
- HRMY $26.47
- TRMD $13.60
- 52 Week High
- HRMY $41.61
- TRMD $40.47
- Technical
- Relative Strength Index (RSI)
- HRMY 58.91
- TRMD 57.27
- Support Level
- HRMY $31.70
- TRMD $17.24
- Resistance Level
- HRMY $35.08
- TRMD $18.15
- Average True Range (ATR)
- HRMY 0.95
- TRMD 0.49
- MACD
- HRMY 0.27
- TRMD 0.03
- Stochastic Oscillator
- HRMY 71.80
- TRMD 67.57
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About TRMD TORM plc
TORM PLC operates as a shipping company. The company owns and operates product tankers. It is engaged in the transportation of refined oil products The company transports clean petroleum products including gasoline, jet fuel, naphtha, and diesel oil, as well as other clean products. Its segments include the Tanker segment, and Marine Engineering segment. The company derives maximum revenue from Tanker segment.